The Knight Cancer Institute is calling for proposals for this year’s Cancer Research Development Awards. The purpose of this funding mechanism is to cultivate outstanding cancer research by assisting in the generation of preliminary data for peer-reviewed national funding and career development proposals. This mechanism is intended to support clinical, basic, or population-based research that is cancer focused. Scientific excellence will be the key review element for all applications. Interdisciplinary research, in which investigators from disparate scientific areas collaborate to bring unique approaches to the cancer problem, is required.
This year, thanks to the generous support of our donors, three one-year $10,000 research development awards are offered:
- Cathy and Jim Career Development Award for Cancer Research
- U.S. Bank Cancer Research Development Award
- Oregon Cancer Ski Out Cancer Research Development Award
Eligible applicants include faculty within five years of their first faculty appointment and senior-level trainees (e.g. senior post-doctoral fellows without faculty rank of assistant professor). Individuals must not yet have received independent R01-comparable research funding.
Application deadline: December 6, 2013
Learn more about the Knight Cancer Institute Cancer Research Development Award program.
Please submit applications via email to Knight Grants Management Team. Direct all questions to Kristin Bialobok.
Take a look at other recent funding opportunities.
The Department of Public Health & Preventive Medicine invites you to attend an information session about our master’s degree and graduate certificate in biostatistics. The session consists of a brief introduction and presentation as well as an opportunity to ask questions. Light refreshments will be provided.
OHSU Degrees in Biostatistics Information Session
Tuesday, November 12, 2013
12:30 to 1:30pm
Hatfield Research Center, room HRC14D03
The MS and MBST in biostatistics programs will provide graduate level training in the application and theory of biostatistics to those wishing to pursue a career as an intermediate level biostatistician or to apply for doctoral programs in biostatistics. Both programs are also appropriate for individuals who have earned a graduate certificate in biostatistics at OHSU and wish to pursue further training.
Learn more about graduate degrees at OHSU.
Please feel free to contact us at firstname.lastname@example.org with questions.
Eric Gouaux, Ph.D.
New research from the lab of Eric Gouaux, Ph.D., senior scientist at OHSU’s Vollum Institute and Howard Hughes Medical Institute Investigator, reveals how neurotransmitters in the brain interact with antidepressants. These findings were published in the November 7 edition of Nature.
The first paper, “X-ray structure of dopamine transporter elucidates antidepressant mechanism,” uses structural biology techniques to improve our understanding of the dopamine transporter. These new insights about the structure of the dopamine transporter may help other scientists develop better targeted antidepressants with fewer side effects. Co-authors on this paper include Aravind Penmatsa, Ph.D., and Kevin Wang, Ph.D., both postdoctoral fellows in Dr. Gouaux’s lab.
A second, complementary paper by Dr. Gouaux and his colleagues was also published today in Nature. This paper, “Structural basis for action by diverse antidepressants on biogenic amine transporters,” describes how the researchers made an amino acid transporter that more closely resembles the human neurotransmitter transporter proteins targeted by antidepressants. They used this transporter to further understanding on how four different types of antidepressants work. Co-authors on this paper include Hui Wang, Ph.D., April Goehring, Ph.D., Kevin Wang, Aravind Penmatsa, and Ryan Ressler, Ph.D.
Check out the OHSU News release for more information.
Both papers were funded by the American Heart Association, the National Institute of Mental Health, (1F32MH093120 and 5R37MH070039) and the Howard Hughes Medical Institute.
The OHSU Native American Employee Resource Group and the Center for Diversity & Inclusion invite all to attend what promises to be an insightful lecture by Capt. Thomas Weiser, M.D., M.P.H., titled, “The Importance of Culture: What a Career in Indian Health Has Taught Me.” Dr. Weiser, a medical epidemiologist for the Portland Area Indian Health Service, will highlight some of his experiences working with American Indian and Alaska Native peoples and discuss the importance of cultural sensitivity and relevance when working in two worlds of Indian health care delivery and service: Western medicine and traditional healing.
Date: Thursday, November 21, 2013
Time: Noon to 1 p.m.
Location: OHSU Old Library Auditorium
About Dr. Weiser
Dr. Weiser has been with Portland Area Indian Health Services since 1998, initially serving as an Indian Health Services Medical Officer in Whiteriver, Arizona from 1998-2005. He completed the CDC Epidemiology Intelligence Service from 2005-2007, assigned to the Missouri Department of Health and Senior Services. In 2007, he began his new position assigned to the Northwest Portland Area Indian Health Board and Northwest Tribal Epidemiology Center. Dr. Weiser is passionate about improving the quality of healthcare services, data access and data quality for American Indian and Alaska Native populations; human subjects protection; infectious disease epidemiology and surveillance.
The Native American Employee Resource Group is a resource throughout OHSU and to community members interested in Native American culture, issues, and health. The Group provides educational outreach spread awareness, and promote thoughtful discussion between members and allies. To learn more, email Michelle Singer or call (503) 494-5657
The American Asthma Foundation seeks to draw outstanding early to mid-career scientists from other fields into the study of asthma. The Scholars Program is designed to achieve this goal by supporting highly innovative research from all fields relevant to asthma. Most Scholars will be studying asthma for the first time.
Award: Up to $150,000 per year for up to three years.
Deadline: February 12, 2014
Eligibility: Applicants should have an independent research program, with national-level, independent funding. The applicant will have been appointed to an independent faculty position no more than 10 years before the application deadline.
For more information about this opportunity visit the American Asthma Foundation website.
For other funding opportunities, take a look at this week’s Funding Alerts.
The Oregon Clinical & Translational Research Institute has funded three projects designed to enhance translational research at OHSU. These novel, collaborative, multidisciplinary studies will lead to further research and funding in translational research.
- Penelope Hogarth
“Neurodegeneration with Brain Iron Accumulation: Research Cohort Developement”
- Cynthia McEvoy
“From Mother to Baby: Blocking Lung Disease and the Epigenetic Changes in Childhood Caused by Maternal Smoking During Pregnancy”
- Garet Lahvis
“Oregon Animation Test for Social Reciprocity”
For full project abstracts visit OCTRI Pilot Project Awards 2014.
OCTRI Catalyst funding is specifically intended to enable the development of compelling new grant applications that will sustain the proposed research activity. Please see the OCTRI Funding Opportunities page for more information or contact Colleen Lay.
The OHSU School of Medicine is accepting proposals to fund gatherings such as symposia, conferences, workshops and retreats that advance the aims of the School of Medicine’s Research Roadmap. These grants (up to $8,000 each) should achieve one or more of the following collaborative outcomes:
- Support the advancement of an emerging area of research that promotes the progression of basic discovery to clinical impact
- Assist faculty in the pursuit of external awards to fund multidisciplinary collaboration
- Support opportunities for strategic planning during the development of research collaborations
Examples of possible events which would merit funding through these grants include:
- A scientific symposium, with one or more invited speakers, to expose the OHSU research community to an area of emerging research and to develop collaborations
- Structured activities designed to bring faculty members from across different departments together to prepare a joint research grant such as a Program Project grant
- A strategic planning retreat for members of a collaborative research group to share scientific findings and strengthen relationships between researchers from different disciplines
- A grant writing workshop with an external consultant to assist faculty in the development of proposals for interdisciplinary collaborations
The lead applicant(s) must have a School of Medicine faculty appointment to be eligible.
Proposals are due December 13, 2013 for funding in fiscal year 2014. View the full program announcement for more information.
Read about projects funded last fiscal year.
In about two months, eCRIS, OHSU’s new clinical research management system, will be required for all new clinical studies enrolling prospectively consented human subjects. Later in 2014, eCRIS will become mandatory for existing studies as well.
As of October, about 100 people have been trained on eCRIS and 60 new studies have voluntarily made the transition. While eCRIS was designed to make your life easier, new users have found that it’s harder to learn when they don’t understand the whole life cycle of a clinical trial. To ensure that users feel prepared for eCRIS, it’s strongly recommended that users brush up on clinical trials basics over the next few months. Use the links below to sign up for training or visit the eCRIS information website.
The OHSU Gene Therapy Working Group and the Rare Disorders Research Consortium invite you to attend the 2nd Annual Gene Therapy Symposium, an afternoon event to showcase OHSU’s Gene Therapy research excellence.
“Gene Therapy at OHSU”
Thursday, November 21, 2013
2 to 6:30 p.m.
The Joseph Vey Conference Center
Featuring “Genes and Non Coding RNAs as Therapeutics” by keynote speaker Mark A. Kay, M.D., Ph.D., Dennis Farrey Family Professor, Departments of Pediatrics and Medical Genetics, Stanford University School of Medicine.
Download symposium schedule.
Gene therapy is finally enjoying success in many clinical trials around the world. Here at OHSU, we have several laboratories doing excellent research in this area, but our efforts are dispersed and could benefit from more integration. In order to build and enhance our Gene Therapy Community we are holding a half-day symposium that includes:
- Keynote address by Mark Kay, M.D., Ph.D.
- Research vignettes from OHSU gene therapy leaders
- Poster session and reception with wine, beer and hors d’oeuvres
Register for the symposium or submit a poster presentation.
Registration deadline is Wednesday, November 6. Please share information about this event with trainees and other members of your research group and collaborators. Both faculty and trainee posters are welcome!
This event is sponsored by the Department of Pediatrics and the Papé Family Pediatric Research Institute. Have questions or need more information? Contact Leslie Lublink.
Are you submitting a Career Development K award this fall?
Or your first R01? A similar major grant?
The Oregon Clinical and Translational Research Institute (OCTRI) has an opportunity for basic and clinical scientists to present their research and get constructive feedback from OHSU scientists to improve their chances of success. The OCTRI Design Studio has helped many OHSU researchers improve their aims and identify important areas of improvement before submitting awards.
The Design Studio has openings at three scheduled meetings for this fall and winter:
- Monday, November 18, 1 to 3 p.m.
- Monday, December 16, 1 to 3 p.m.
- Tuesday, January 14, 12 to 2 p.m.
OCTRI’s Design Studio has been a great opportunity for basic scientists as well as clinical scientists at all levels of training. Learn more about Design Studio, or contact Karen McCracken about presenting at an upcoming Design Studio.